论文信息 - First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers - 字舞流文

First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers

G. Zalcman | C. Morimoto | P. Vielh | K. Ohnuma | N. Dang | Y. Kaneko | Taketo Yamada | N. Isambert | V. Trillet-lenoir | E. Angevin | O. Hosono | F. Farace | J. Alexandre | B. You | F. Valleix | Thomas Podoll | Y. Kuramochi | I. Miyashita | V. Trillet‐Lenoir